White Paper

Take Control Of Patient Recruitment

Source: Trialbee AB
patient diversity iStock-171586264

Recruitment and enrollment in clinical trials remain key sources of cost and frustration for sponsors. Recent data shows that nearly 80% of trials fail to meet enrollment timelines and that approximately one  third of all Phase III study terminations are a result of poor enrollment. These persistent challenges can lead study leaders to feel helpless. Traditionally, study teams have had little to no control over study recruitment and, as time has passed, the belief that recruitment must be difficult and chaotic has grown roots. Many feel that lengthy recruitment periods and over-recruiting are unavoidable constants and
that, in terms of enrollment diversity, you simply get what you get.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader